OncoCyte Corporation (OCX) has a market capitalization of $91.52M and trades at $3.20. The 52-week range is 1.922-4.75.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.9, Earnings Per Share (EPS) of $-1.65, annual revenue of $4.06M.
The stock has a beta of 0.99, operates in the Healthcare sector.
